Dr. Jeffrey Olin, DO

Dr. Olin practices at The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System.

Dr. Olin's NPI, 1144258609, was assigned on June 30, 2006. Dr. Olin graduated from University of Kansas School of Med (KC/Wich/Sal) in 1977. Dr. Olin holds New York license 223495.

Dr. Olin's primary practice is The Mount Sinai Hospital, at One Gustave L Levy Place, New York, NY 10029 in New York County. The practice phone is (212) 241-7981. Dr. Olin also practices at The Mount Sinai Hospital, 1 Gustave L Levy Pl, New York, NY 10029.

Dr. Olin's primary practice is The Mount Sinai Hospital in New York, New York, part of Mount Sinai Health System. Dr. Olin is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Mount Sinai Institute for Liver Medicine. Dmand AI also links Dr. Olin to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Olin practices, 4 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Olin's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Olin is licensed in New York.

CMS data shows 1,418 Medicare services from Dr. Olin across 14 procedure codes in 2024, for 1,029 Medicare patients. Medicare paid $54,861 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 1,029 Medicare patients who saw Dr. Olin in 2024. The largest group is 75 to 84, with 426 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Olin's median patient age at 66, with 55% women.

In 2024, Dr. Olin wrote 488 Medicare Part D claims for 75 patients. 91% of them were for generic drugs. CMS names the drug for 427 of them, across 15 drugs with 11 or more claims each, at $48,721 in total drug cost. In 2023, CMS named 496 claims across 16 drugs.

Dr. Olin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Olin as offering telehealth.

Dmand AI links 180 papers to Dr. Olin, published from 2002 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Fibromuscular Dysplasia, Peripheral Arterial Disease and Stents. Dr. Olin has published most often in Vasc Med. Dr. Olin's most frequent co-authors are Daniella Luiza Kadian-Dodov, MD, Bruce Harvey Gray, DO and Michael Ritt Jaff, DO.

CMS Open Payments shows 56 general payments to Dr. Olin from 6 drug and device companies from 2016 to 2024. Consulting fees make up the largest share, 77% of the total. Janssen Pharmaceuticals, Inc paid the most, $32,550. It also lists 2 research payments totaling $28,842 in 2016.

Dmand AI lists 5 awards for Dr. Olin, most recently New York Magazine: Top Doctors in 2016.

Dr. Olin graduated from University of Kansas School of Med (KC/Wich/Sal) in 1977.

Dr. Olin is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.